Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 2.58B | 2.92B | 3.13B | 2.88B | 1.96B |
Gross Profit | 172.05M | 332.96M | 329.61M | 458.81M | 234.65M |
EBITDA | 260.67M | 406.97M | 412.42M | 564.65M | 351.78M |
Net Income | 84.61M | 190.08M | 194.38M | 266.08M | 125.28M |
Balance Sheet | |||||
Total Assets | 2.02B | 2.10B | 1.87B | 1.84B | 1.76B |
Cash, Cash Equivalents and Short-Term Investments | 702.10M | 797.81M | 535.47M | 425.06M | 367.10M |
Total Debt | 28.14M | 28.04M | 28.36M | 124.29M | 319.40M |
Total Liabilities | 211.98M | 334.04M | 248.69M | 361.52M | 524.98M |
Stockholders Equity | 1.80B | 1.76B | 1.61B | 1.47B | 1.23B |
Cash Flow | |||||
Free Cash Flow | -68.89M | 302.42M | 261.12M | 271.56M | 134.97M |
Operating Cash Flow | 119.76M | 372.77M | 306.18M | 350.37M | 312.88M |
Investing Cash Flow | -171.00M | -62.89M | -36.38M | -48.25M | -169.90M |
Financing Cash Flow | -50.99M | -53.16M | -159.45M | -238.97M | -203.52M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
69 Neutral | HK$1.06B | 11.51 | 4.75% | 2.12% | -13.75% | -56.14% | |
58 Neutral | HK$16.70B | 4.48 | -5.92% | 5.25% | -3.57% | -61.41% | |
54 Neutral | HK$1.03B | 14.10 | 2.75% | 3.28% | -11.89% | -69.45% | |
53 Neutral | HK$2.03B | 3.41 | 11.49% | ― | 47.32% | 492.76% | |
53 Neutral | HK$2.03B | 3.41 | 11.49% | ― | 47.32% | 492.76% | |
46 Neutral | HK$148.32M | ― | -10.94% | ― | -9.85% | 20.22% | |
45 Neutral | HK$1.57B | 106.12 | 2.19% | ― | 17.98% | 374.19% | |
45 Neutral | HK$1.57B | 106.12 | 2.19% | ― | 17.98% | 374.19% | |
36 Underperform | HK$156.73M | ― | -76.72% | ― | -12.18% | -222.34% |
Dongguang Chemical Limited has established a Nomination Committee as part of its Board of Directors, effective from July 1, 2025. This committee, formed to enhance corporate governance, will consist of at least three members, including a diverse representation and a majority of independent non-executive directors, reflecting the company’s commitment to diversity and independence in its leadership structure.
Dongguang Chemical Ltd. announced the successful passing of all ordinary resolutions at its Annual General Meeting held on May 22, 2025. The meeting marked the retirement of non-executive director Ms. Chen Jimin and the re-election of directors, approval of financial statements, declaration of a final dividend, and reappointment of auditors. These resolutions are expected to strengthen the company’s governance and operational framework.
Dongguang Chemical Ltd. has announced the composition of its board of directors and their respective roles within the company. The board includes both executive and independent non-executive directors, with specific members assigned to various committees such as Audit, Remuneration, Nomination, and Corporate Governance. This announcement provides clarity on the company’s governance structure, potentially impacting its strategic direction and stakeholder confidence.
Dongguang Chemical Ltd. has announced its annual general meeting scheduled for May 22, 2025, where key agenda items include the approval of financial statements, declaration of a final dividend, re-election of directors, and reappointment of auditors. The meeting will also address resolutions to authorize the board to manage share allotments, potentially impacting the company’s capital structure and shareholder value.